Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2476 AL 2490

Neuropsychological aspects of impulse control disorders in Parkinson's disease

Scanferla L, Djamshidian A.

Front Aging Neurosci. 2026 Mar 9;18:1768251. doi: 10.3389/fnagi.2026.1768251. eCollection 2026.

Adult Neurogenesis in Neurodegenerative Diseases: Mechanisms of Dysregulation in Alzheimer's and Parkinson's Disease

Dębiec M, Rojek M.

Int J Mol Sci. 2026 Mar 17;27(6):2742. doi: 10.3390/ijms27062742.

[Relationship between kidney-related brain dysfunction and neuropathological changes in Parkinson's disease]

Yusupov FA, Abdykadyrov MS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(3):30-37. doi: 10.17116/jnevro202612603130.

Energy metabolic failure drives the selective degeneration of dopaminergic neurons in Parkinson's disease

Zhou Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Apr 28;147:111722. doi: 10.1016/j.pnpbp.2026.111722. Online ahead of print.

Psychiatric and behavioral disorders in Parkinson's disease: co-pathogenic mechanisms of tau, Aβ, and α-synuclein proteins (narrative review)

Chai JY, Zhang Y, Zhang ZQ, Ma DR, Cao YH, Zhu SR, Ma YZ, Luo LL, Zhan YL, Fan ZY, Lan R.

Rev Neurosci. 2026 May 14. doi: 10.1515/revneuro-2026-0041. Online ahead of print.

Immune crosstalk in Alzheimer's and Parkinson's disease: insights from Drosophila models into the brain-peripheral immune axis

Parvez F, Rahul.

Front Immunol. 2026 Jan 27;17:1725046. doi: 10.3389/fimmu.2026.1725046. eCollection 2026.

Unlocking the potential of lipid-based nanoparticles for intranasal drug delivery in Parkinson's disease

Geremamo YD, Hasan A, Razzak SA, Uddin S.

Int J Pharm. 2026 Mar 10;692:126604. doi: 10.1016/j.ijpharm.2026.126604. Epub 2026 Jan 27.

Mitophagy-NLRP3 Inflammasome Crosstalk in Parkinson's Disease: Pathogenic Mechanisms and Emerging Therapeutic Strategies

Ahmed S, Pasam T, Afreen F.

Int J Mol Sci. 2026 Jan 3;27(1):486. doi: 10.3390/ijms27010486.

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Chaudhuri KR, Bergmans B, Freire-Alvarez E, Hopes L, Kern DS, Kirsner RS, Lazzeri G, Mendes-Bastos P, Nishikawa N, Odin P, Poplawska-Domaszewicz K, Pahwa R, Ramot Y, Seppi K, Warnecke T, Wiggins R, Shah MB, Kukreja P, Fritz B, Onuk K, Isaacson SH.

Mov Disord Clin Pract. 2026 Jan 16. doi: 10.1002/mdc3.70489. Online ahead of print.

"Unfolding Parkinson's Disease Through the Microbiome-Gut-Brain Axis"

Shenthilvel RK, Umashankar TA, Uvarajan D, Mathuraj M, Ravikumar M.

J Mol Neurosci. 2026 Feb 5;76(1):25. doi: 10.1007/s12031-025-02462-0.

Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches

Liu J, Yu D, Liu Y, Yong Y, Wang Z, Fan P, Yang X.

Neurobiol Dis. 2026 Mar;220:107316. doi: 10.1016/j.nbd.2026.107316. Epub 2026 Feb 9.

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives-A Narrative Review

Munhoz RP, Farah M, Silveira-Moriyama L.

Mov Disord Clin Pract. 2026 Mar 27. doi: 10.1002/mdc3.70610. Online ahead of print.

Bridging Regenerative and Restorative Stem Cell Therapies in Parkinson's Disease

Onuigbo C, Martinez-Lemus J, Tharp E, Schiess M.

Cells. 2026 Mar 25;15(7):578. doi: 10.3390/cells15070578.

Cognitive processes and neurophysiological mechanisms of time processing in Parkinson's disease: A narrative review

Buikema L, Sadikov A, Jahanshahi M, Vinke RS, Georgiev D.

Neurosci Biobehav Rev. 2026 Jul;186:106719. doi: 10.1016/j.neubiorev.2026.106719. Epub 2026 Apr 29.

Stem Cell-Derived Exosomes Regulate Mitochondrial Function: A Novel Strategy for Parkinson's Disease Therapy

Wang J, Wang C, Yuan X, Yan J, Huang H, Li F, You Y, Qi Z.

Mol Neurobiol. 2026 May 2;63(1):603. doi: 10.1007/s12035-026-05887-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias